These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Synthesis of O1.5-(beta-D-galactopyranosyl) [DMet2, Hyp5] enkephalin amide, a new highly potent analgesic enkephalin-related glycosyl peptide. Torres JL; Haro I; Valencia G; Reig F; García-Antón JM Experientia; 1989 Jun; 45(6):574-6. PubMed ID: 2737265 [TBL] [Abstract][Full Text] [Related]
25. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Mellon RD; Bayer BM Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057 [TBL] [Abstract][Full Text] [Related]
26. Species differences in the relative analgesic potencies of some classical opiates and opioid peptides. Székely JI; Miglécz E; Bajusz S Psychopharmacology (Berl); 1984; 82(4):400-2. PubMed ID: 6328558 [TBL] [Abstract][Full Text] [Related]
27. Age-related changes in the spinal antinociceptive effects of DAGO, DPDPE and beta-endorphin in the rat. Crisp T; Stafinsky JL; Hoskins DL; Perni VC; Uram M; Gordon TL Brain Res; 1994 Apr; 643(1-2):282-6. PubMed ID: 8032922 [TBL] [Abstract][Full Text] [Related]
28. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537 [TBL] [Abstract][Full Text] [Related]
29. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury. Ossipov MH; Lopez Y; Bian D; Nichols ML; Porreca F Anesthesiology; 1997 Jan; 86(1):196-204. PubMed ID: 9009955 [TBL] [Abstract][Full Text] [Related]
30. In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog. Székely JI; Dunai-Kovács Z; Miglécz E; Rónai AZ; Bajusz S J Pharmacol Exp Ther; 1978 Dec; 207(3):878-83. PubMed ID: 731437 [TBL] [Abstract][Full Text] [Related]
31. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors. Ochi T; Fujii T; Motoyama Y; Goto T Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565 [TBL] [Abstract][Full Text] [Related]
32. Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla. Fang FG; Haws CM; Drasner K; Williamson A; Fields HL Brain Res; 1989 Oct; 501(1):116-28. PubMed ID: 2572306 [TBL] [Abstract][Full Text] [Related]
33. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests. Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557 [TBL] [Abstract][Full Text] [Related]
34. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats. Brady LS; Holtzman SG J Pharmacol Exp Ther; 1981 Nov; 219(2):344-51. PubMed ID: 7197301 [TBL] [Abstract][Full Text] [Related]
35. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350 [TBL] [Abstract][Full Text] [Related]
36. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. Qi JN; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801 [TBL] [Abstract][Full Text] [Related]
37. Modulation of the analgesic efficacy and potency of morphine by [D-Pen2, D-Pen5]enkephalin in mice. Jiang Q; Mosberg HI; Porreca F Prog Clin Biol Res; 1990; 328():449-52. PubMed ID: 2154803 [No Abstract] [Full Text] [Related]
38. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711 [TBL] [Abstract][Full Text] [Related]
39. Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration. Locatelli V; Cocchi D; Bajusz S; Spampinato S; Müller EE Experientia; 1978 Dec; 34(12):1650-1. PubMed ID: 729748 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice. Ueda H; Amano H; Shiomi H; Takagi H Eur J Pharmacol; 1979 Jun; 56(3):265-8. PubMed ID: 582583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]